Imaging with the glucose analog [18F]FDG is particularly useful in aggressive NEN, such as well-differentiated NET G3 or poorly differentiated NEC, characterized by a high Ki-67 index and typically lower tumor SSR expression. This evidence concerns the gene MKI67 and neoplasm.